Literature DB >> 3666962

Intrapulmonary growth of Staphylococcus aureus in rats during induced atelectasis.

D Frederick1, E L Pesanti.   

Abstract

Intrinsic pulmonary antibacterial defenses are mediated by alveolar macrophages and by noncellular factors. Mechanical ventilation in the resting tidal volume range leads to alterations in the physical characteristics of alveolar surfactant, alveolar instability, regional hypoxia, and systemic hypoxemia. While a number of experimental manipulations diminish the activity of the intrinsic antibacterial defense system, the effects of mechanical ventilation per se have not been systematically evaluated previously. We found that normal rats ventilated without sighing (periodic large breaths) manifested severe defects in pulmonary clearance of Staphylococcus aureus during 6-h experiments, such that growth of the inoculum occurred. Addition of a timer-controlled mechanism to cause the animals to sigh every 2 min, without other modifications in the experimental conditions, caused significant improvement in clearance. Analysis of cellular response, compartmentalization of viable bacteria, surfactant quantities and sedimentation characteristics, and protein influx indicated that the defect in clearance paralleled alterations in the physical state of surfactant and alveolar stability but was not strongly correlated with alterations in the other parameters we measured. The data show that defective pulmonary bacterial clearance is rapidly induced by measures which alter alveolar stability and suggest that intrinsic pulmonary defenses require maintenance of normal air-liquid interfaces for optimal function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3666962      PMCID: PMC259971          DOI: 10.1128/iai.55.11.2747-2753.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Determinants of lung bacterial clearance in mice after acute hypoxia.

Authors:  G D Harris; W G Johanson; A K Pierce
Journal:  Am Rev Respir Dis       Date:  1977-10

2.  Bactericidal effects of polyunsaturated fatty acids.

Authors:  H R Knapp; M A Melly
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

3.  Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material.

Authors:  F M LaForce; W J Kelly; G L Huber
Journal:  Am Rev Respir Dis       Date:  1973-10

4.  Morphologic evidence that large inflations of the lung stimulate secretion of surfactant.

Authors:  G D Massaro; D Massaro
Journal:  Am Rev Respir Dis       Date:  1983-02

5.  Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus.

Authors:  J M Onofrio; G B Toews; M F Lipscomb; A K Pierce
Journal:  Am Rev Respir Dis       Date:  1983-03

6.  Adaptations of phagocytosis and pinocytosis in mouse lung macrophages after sustained in vitro hypoxia.

Authors:  L M Simon; S G Axline; E L Pesanti
Journal:  Am Rev Respir Dis       Date:  1981-01

7.  Staphylococcal clearance and pulmonary macrophage function during influenza infection.

Authors:  K M Nugent; E L Pesanti
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages.

Authors:  S O'Neill; E Lesperance; D J Klass
Journal:  Am Rev Respir Dis       Date:  1984-08

9.  Characterization of the extracellular bactericidal factors of rat alveolar lining material.

Authors:  J D Coonrod; R L Lester; L C Hsu
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Role of lysozyme in the microbicidal activity of rat alveolar macrophages.

Authors:  W D Biggar; J M Sturgess
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

View more
  1 in total

1.  Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia.

Authors:  R K L Bouhafs; C Jarstrand; B Robertson
Journal:  Lung       Date:  2004       Impact factor: 2.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.